MTBC to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in NYC
NEW YORK, NY–(Marketwired – Aug 17, 2017) – MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a provider of proprietary, cloud-based healthcare IT solutions and services, announced today that it will be presenting at the Rodman & Renshaw 19th Annual Global Investment Conference, to be held on September 10-12, 2017, at the Lotte New York Palace Hotel in New York, NY. The MTBC presentation will occur on September 11, 2017 at 4:40 PM EDT in the Adams Room.
“The Rodman & Renshaw Global Investment Conference provides investors with an opportunity to meet MTBC’s management team and understand the Company’s business,” said Bill Korn, Chief Financial Officer. “We will discuss how MTBC achieved 55% revenue growth in the first half of 2017 while reporting its highest adjusted EBITDA ever as a public company during second quarter 2017, and expectations for the future.”
This conference will provide investors the chance to learn more about MTBC firsthand, and to meet the leadership team. Bill Korn, together with Mahmud Haq, CEO, and Stephen Snyder, President, will be presenting at the conference and meeting with investors one-on-one throughout the day on Monday and Tuesday.
The presentation will also be available by live webcast on MTBC’s investor relations website at ir.mtbc.com/events.cfm. Please visit MTBC’s Investor Relations website at ir.mtbc.com to view the MTBC Fact Sheet, Corporate Presentation, listen to interviews with the MTBC leadership team, and to listen to a replay of the webcast which will be available through March 31, 2018.
The Rodman & Renshaw conference consists of over 300 presenting companies and 2,000 attendees, bringing growth companies together with a vast audience of financial and strategic investors. In addition to corporate presentations, Rodman facilitates one-on-one investor meetings and provides platforms for engaged Q&A sessions.
MTBC is a healthcare information technology company that provides a fully integrated suite of proprietary web-based and mobile health solutions, together with related business services, to healthcare providers throughout the United States. Its integrated SaaS platform helps its customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC’s common stock trades on the NASDAQ Capital Market under the ticker symbol “MTBC,” and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol “MTBCP.”
Company and Investor Contact:
Chief Financial Officer
Medical Transcription Billing, Corp.